NEONATAL GRAVES’ DISEASE

AN UNUSUAL METABOLIC AND CARDIAC ASSOCIATION FROM PRESENTATION TO RESOLUTION

Authors

  • Puvanesvaran Ramachandran Paediatric Endocrine Unit, Department of Paediatrics, Hospital Tunku Azizah Kuala Lumpur, Malaysia
  • Arini Nuran Idris Paediatric Endocrine Unit, Department of Paediatrics, Hospital Tunku Azizah Kuala Lumpur, Malaysia
  • Tee Pian Pian Paediatric Endocrine Unit, Department of Paediatrics, Hospital Tunku Azizah Kuala Lumpur, Malaysia
  • Farah Inaz Neonatology Unit, Department of Paediatrics, Hospital Tunku Azizah Kuala Lumpur. Malaysia
  • Lilian Ngo Ping Ling Neonatology Unit, Department of Paediatrics, Hospital Tunku Azizah Kuala Lumpur. Malaysia
  • Amelia Alias Paediatric Cardiology Unit, Department of Paediatrics, Hospital Tunku Azizah Kuala Lumpur, Malaysia
  • Kam Choy Chen Paediatric Gastroenterology Unit, Department of Paediatrics, Hospital Tunku Azizah Kuala Lumpur, Malaysia
  • Lim Poi Giok Paediatric Endocrine Unit, Department of Paediatrics, Hospital Tunku Azizah Kuala Lumpur, Malaysia

Keywords:

Nenonata's Grave's disease

Abstract

INTRODUCTION

Neonatal Graves’ disease is a rare disorder seen in 1 in 25000 births, caused by transplacental passage of TSH receptor antibody. Despite serious potential multisystem complications, it can be transient.

METHODOLOGY

We describe a newborn born to a mother with undiagnosed Graves' disease.

RESULTS

A male neonate was born prematurely at 31-weeks gestation via emergency lower segment caesarean for fetal distress with a birth weight of 1.7 kg. He was admitted to the neonatal intensive care unit due to respiratory distress requiring non-invasive ventilation. Newborn examination revealed hepatosplenomegaly with conjugated hyperbilirubinemia, hence, he was empirically treated for congenital infections. At 72 hours, the patient developed tachycardia and further work up resulted in suppressed cTSH. At that time mother was incidentally noted to have features of clinical Graves' disease which was confirmed by 2 thyroid function tests and positive TSH receptor antibody. Further radiological assessment of the newborn revealed periportal fibrosis and pulmonary hypertension. He was commenced on carbimazole and short course of prednisolone which resulted in resolution of hyperthyroidism, pulmonary hypertension, periportal fibrosis and thrombocytopenia.

CONCLUSION

Pulmonary hypertension and periportal fibrosis are rare clinical manifestations of neonatal Graves' disease which
are reversible with resolution of hyperthyroidism.

Downloads

Download data is not yet available.

References

*

Downloads

Published

2022-07-15

How to Cite

Ramachandran, P., Idris, A. N., Pian Pian, T., Inaz, F., Ling, L. N. P., Alias, A., … Giok, L. P. (2022). NEONATAL GRAVES’ DISEASE: AN UNUSUAL METABOLIC AND CARDIAC ASSOCIATION FROM PRESENTATION TO RESOLUTION. Journal of the ASEAN Federation of Endocrine Societies, 37, 56–57. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/2227

Most read articles by the same author(s)